U-NEURON Unveils i-ExoCraft® Exosome Platform, Pioneering Integrated Design and Manufacturing

U-NEURON Unveils i-ExoCraft® Exosome Platform, Pioneering Integrated Design and Manufacturing - 永立榮生醫

Exosome technology development draws widespread attention as industry, government, and academic leaders gather for strategic exchange. (Photo / Provided by Event Organizer)

On March 22, U-NEURON (Stock Code: 6973) held its “Intelligent Integrated Exosome Design & Manufacturing Platform and Next-Generation Applications Launch Event” at the Grand Hyatt Taipei, officially launching the “i-ExoCraft® Intelligent Integrated Exosome Design & Manufacturing Platform.” The event drew nearly 200 participants spanning academic R&D, industry experts, health management brands, and investment professionals to witness the exosome sector advance into a new phase of platformization and customized functional design.

U-NEURON Unveils i-ExoCraft® Exosome Platform, Pioneering Integrated Design and Manufacturing - 永立榮生醫

Representatives from government, industry, and academia gathered at U-NEURON’s exosome platform launch event to witness a key milestone in industry development. (Photo / Provided by Event Organizer)

The event convened prominent leaders across government, industry, and academia, including former Minister of Economic Affairs Kuo Jyh-huei and Taiwan-Africa Economic and Development Association Chairman Huang Chih-peng. Former Minister Kuo noted that global biomedical technology is advancing toward regenerative medicine and precision applications, with exosome technologies rapidly becoming a central focus. Taiwan’s world-class “Design × Manufacturing” competitive advantages established in the semiconductor sector now have the opportunity to extend into the biomedical domain, driving overall industry upgrading and global competitiveness.

Huang Chih-peng highlighted that as healthcare and biotech application demands expand across emerging markets in Southeast Asia and Africa, industry competition is shifting from isolated products toward comprehensive capabilities integrating technology, applications, and market execution. Platform technologies with strong cross-domain integration potential will help Taiwan’s biomedical sector interface globally and expand collaborative opportunities.

The newly unveiled i-ExoCraft® platform introduces the semiconductor industry’s “Design House × Foundry” operational framework, emphasizing end-to-end integration from upstream design to downstream manufacturing. By combining R&D capabilities with advanced processing workflows, the platform delivers customized design and manufacturing support tailored to diverse client requirements, enabling exosomes to evolve from standard raw material supplies into functional applications and engineered product designs.

U-NEURON Unveils i-ExoCraft® Exosome Platform, Pioneering Integrated Design and Manufacturing - 永立榮生醫

U-NEURON Chairman Dr. Frank Chien (right) pictured with Chlitina Group Chairwoman Chen Pi-hua. (Photo / Provided by Event Organizer)

U-NEURON Chairman Dr. Frank Chien stated that the company has long been dedicated to regenerative medicine, building a solid R&D foundation and manufacturing expertise while expanding into diverse application scenarios. The launch of the i-ExoCraft® platform symbolizes the systematic platformization of U-NEURON’s existing technologies, delivering flexible and integrated service models that help partners accelerate product development and commercial deployment.

Regarding overall business operations, U-NEURON continues to strengthen supply chain integration spanning raw material development, product design, and manufacturing services. The company has established strategic partnerships with multiple commercial brands, penetrating skincare and health management markets to drive steady operational growth.

The establishment of the Exosome R&D Pilot Manufacturing Center in Hsinchu further bridges R&D and production capabilities while embedding a design-driven service model. This platform upgrade marks an industry shift from raw material supply toward holistic solutions and functional application design.

Looking ahead, U-NEURON will continue deepening technology integration and international commercial partnerships, reinforcing Taiwan’s industrial advantages in biotechnology. Through its platform-based growth model, the company aims to expand exosome applications into broader market segments, unlocking further growth momentum across the sector.

https://www.youtube.com/watch?v=gzCUDRtMRNY&feature=youtu.be

https://act.chinatimes.com/market/content.aspx?AdID=20814&chdtv